skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Enantioselective Synthesis of a PKC Inhibitor via Catalytic C-HBond Activation

Abstract

The syntheses of two biologically active molecules possessing dihydropyrroloindole cores (1 and 2) were completed using rhodium-catalyzed imine-directed C-H bond functionalization, with the second of these molecules containing a stereocenter that can be set with 90% ee during cyclization using chiral nonracemic phosphoramidite ligands. Catalytic decarbonylation and direct indole/maleimide coupling provide efficient access to 2.

Authors:
; ; ;
Publication Date:
Research Org.:
Ernest Orlando Lawrence Berkeley NationalLaboratory, Berkeley, CA (US)
Sponsoring Org.:
USDOE Director. Office of Science. Office of Basic EnergySciences. Chemical Sciences Geosciences and Biosciences Division; National Institutes of Health Grant GM069559
OSTI Identifier:
908170
Report Number(s):
LBNL-59469
Journal ID: ISSN 1523-7060; XX5305; R&D Project: 402101; BnR: KC0302010; TRN: US200722%%516
DOE Contract Number:
DE-AC02-05CH11231
Resource Type:
Journal Article
Resource Relation:
Journal Name: Organic Letters; Journal Volume: 8; Journal Issue: 8; Related Information: Journal Publication Date: 2006
Country of Publication:
United States
Language:
English
Subject:
37; SYNTHESIS; CATALYSIS; MOLECULES; RHODIUM

Citation Formats

Wilson, Rebecca M., Thalji, Reema K., Bergman, Robert G., and Ellman,Jonathan A.. Enantioselective Synthesis of a PKC Inhibitor via Catalytic C-HBond Activation. United States: N. p., 2006. Web. doi:10.1021/ol060485h.
Wilson, Rebecca M., Thalji, Reema K., Bergman, Robert G., & Ellman,Jonathan A.. Enantioselective Synthesis of a PKC Inhibitor via Catalytic C-HBond Activation. United States. doi:10.1021/ol060485h.
Wilson, Rebecca M., Thalji, Reema K., Bergman, Robert G., and Ellman,Jonathan A.. Sun . "Enantioselective Synthesis of a PKC Inhibitor via Catalytic C-HBond Activation". United States. doi:10.1021/ol060485h.
@article{osti_908170,
title = {Enantioselective Synthesis of a PKC Inhibitor via Catalytic C-HBond Activation},
author = {Wilson, Rebecca M. and Thalji, Reema K. and Bergman, Robert G. and Ellman,Jonathan A.},
abstractNote = {The syntheses of two biologically active molecules possessing dihydropyrroloindole cores (1 and 2) were completed using rhodium-catalyzed imine-directed C-H bond functionalization, with the second of these molecules containing a stereocenter that can be set with 90% ee during cyclization using chiral nonracemic phosphoramidite ligands. Catalytic decarbonylation and direct indole/maleimide coupling provide efficient access to 2.},
doi = {10.1021/ol060485h},
journal = {Organic Letters},
number = 8,
volume = 8,
place = {United States},
year = {Sun Feb 26 00:00:00 EST 2006},
month = {Sun Feb 26 00:00:00 EST 2006}
}
  • Native LDL may be a mitogenic stimulus of VSMC proliferation in lesions where endothelial disruption occurs. Recent studies have demonstrated that the mitogenic effects of LDL are accompanied by Erk1/2 activation via an unknown G-protein-coupled receptor (GPCR). In this article, we report that LDL translocated PKC{beta}{sub II} and PKC{theta} from cytosol to plasma membrane, and inhibition of PKC{beta}{sub II} and PKC{theta} decreased LDL effects via the deactivation of Erk1/2. Moreover, pertussis toxin, but not cholera toxin or heparin, inhibited LDL-induced translocation of PKC{beta}{sub II} and PKC{theta}, suggesting that Gi protein plays a role in LDL effects. Of LPA, S1P, andmore » LDL, whose signaling is conveyed via Gi/o proteins, only LDL induced translocation of PKC{beta}{sub II} and PKC{theta}. Inhibition of PKC{beta}{sub II} or PKC{theta}, as well as of Erk1/2 and GPCR, decreases LDL-induced upregulation of Egr-1, which is critical for cell proliferation. This is the first report, to our knowledge, that the participation of PKC{theta} in VSMC proliferation is unique.« less
  • Protein kinase C (PKC) has been shown to exert broad actions in modulating Ca{sup 2+} in cardiac myocytes, however, the effect of PKC in skeletal muscle cells is largely unknown. In this study, we examined the effect of the PKC inhibitor calphostin C (CC) and the PKC agonist phorbol 12-myristate 13-acetate (PMA) on intracellular Ca{sup 2+} handling in C2C12 skeletal myotubes and skinned skeletal muscle fibers of the rat. CC (250 nM) significantly prolonged (P = 0.01, n = 6), and the PKC agonist PMA (500 nM; P = 0.03, n 6) significantly shortened the decay phase of electrically inducedmore » Ca{sup 2+} transients in C2C12 myotubes without affecting the amplitude or the time to peak of the transients. Skinned fiber studies showed that CC significantly inhibits SR Ca{sup 2+} uptake in skeletal muscle cells. PMA had no effect. CC also increased the peak of ATP-induced Ca{sup 2+} transients release by 94.2% (P < 0.0001) in the presence of extracellular Ca{sup 2+} and 54.5% (P = 0.04) without external Ca{sup 2+} via IP{sub 3}-Ca{sup 2+} release pathway in C2C12 myotubes, while PMA had no effect, suggesting that CC may modulate IP{sub 3}-induced Ca{sup 2+} release via a PKC-independent mechanism. CC at a concentration of 1 {mu}M was able to induce a large sustained elevation in basal [Ca{sup 2+}]{sub i} that was blocked by Ca{sup 2+} store depletion and the IP{sub 3} receptor blocker 2-APB. These results indicate that PKC plays a role in modulation of SR function in skeletal muscle cells, and the PKC inhibitor CC may alter Ca{sup 2+} handling via both PKC-dependent and PKC-independent pathways.« less
  • No abstract prepared.
  • Highly enantioselective catalytic intramolecular ortho-alkylation of aromatic imines containing alkenyl groups tethered at the meta position relative to the imine directing group has been achieved using [RhCl(coe){sub 2}]{sub 2} and chiral phosphoramidite ligands. Cyclization of substrates containing 1,1- and 1,2-disubstituted as well as trisubstituted alkenes were achieved with enantioselectivities >90% ee for each substrate class. Cyclization of substrates with Z-alkene isomers proceeded much more efficiently than substrates with E-alkene isomers. This further enabled the highly stereoselective intramolecular alkylation of certain substrates containing Z/E-alkene mixtures via a Rh-catalyzed alkene isomerization with preferential cyclization of the Z-isomer.
  • No abstract prepared.